Alban Bessède

Alban Bessede, PhD, is a highly experienced professional in the field of immunology and biotechnology. Currently serving as the Founder and Chief Executive Officer of Nobel Therapeutics since February 2023, Alban also holds similar positions at Explicyte and ImmuSmol, both established in March 2016 and August 2012, respectively. Explicyte focuses on preclinical and translational research in Immuno-Oncology, providing services such as cell-based assays and patient sample analysis. ImmuSmol specializes in facilitating the visualization and quantification of small molecules through immunoassays. Alban’s academic background includes a post-doctoral fellowship at the University of New South Wales and a PhD in Immunology from the Università per Stranieri di Perugia, where research centered on the immune response and tryptophan metabolites.